News

AVI BioPharma also said that it would be optimizing compounds targeting infectious diseases, and testing new technologies that leverage the Neugene antisense platform, such as exon-skipping pre-RNA interference

This announcement marks the third collaboration between AstraZeneca and BioFocus DPI. In August 2006, Galapagos announced BioFocus DPI’s first drug discovery collaboration with AstraZeneca. Under a second program

GammaCan anticipates filing an IND with the FDA for a Phase I/II clinical trial by year-end, and initiating clinical testing of VitiGam in early 2008. Orphan drug designation

The world’s largest drug company said it currently has 47 drugs in the Phase II stage, 38 in Phase I, and 11 in Phase III. Four drugs at

KineMed’s proprietary reverse cholesterol transport (RCT) technology will be used to evaluate investigational compounds discovered by Merck, the company said. RCT is the only known metabolic pathway by

Angiomax is currently approved for patients undergoing percutaneous coronary intervention, commonly referred to as angioplasty. The Medicines Company also noted that new guidelines released by the American College

Selzentry (maraviroc) blocks viral entry into white blood cells, significantly reducing viral load and increasing T-cell counts in treatment-experienced patients infected with a specific type of HIV. The

So far, the independent data safety monitoring board has reviewed blinded data of over 50 patients; there have been no treatment-related serious adverse events or withdrawals, and the

The seven antibiotics are amoxicillin, cephalexin, sulfamethoxazole/trimethoprim, ciprofloxacin (excluding ciprofloxacin XR), penicillin VK, ampicillin and erythromycin (excluding Ery-Tab). These account for almost 50% of the generic pediatric prescriptions